Company: STAA
Filing Date: 2025-09-16
Form Type: DEFM14A
Source: 0001193125-25-204396
Chunk: 121

Company: STAAR SURGICAL CO
Filing Date: 2025-09-16
Form: DEFM14A
Chunk 121
---
 be entitled to vote their shares of STAAR common stock for
any purpose, or to receive payment of dividends or other distributions on the shares of STAAR common stock, except dividends or other distributions on the person’s shares of STAAR common stock, if any, payable to stockholders of record as of a
time prior to the Effective Time.

Failure to comply strictly with all of the procedures set forth in Section 262 may result in the
loss of statutory appraisal rights. Consequently, any stockholder or beneficial owner wishing to exercise appraisal rights is encouraged to consult legal counsel before attempting to exercise those rights.

STOCKHOLDERS AND BENEFICIAL OWNERS WHO VOTE SHARES IN FAVOR OF THE ADOPTION OF THE MERGER AGREEMENT WILL NOT BE ENTITLED TO EXERCISE APPRAISAL RIGHTS WITH RESPECT THERETO, BUT, RATHER, WILL RECEIVE THE MERGER CONSIDERATION.

To the extent there are any inconsistences between the foregoing summary, on the one hand, and Section 262, on the other hand, Section 262 will govern.

-72-

Litigation Relating to the Merger In connection with the Merger Agreement, an individual lawsuit has been filed by a purported stockholder of STAAR in the United States District Court for the Central District of California, captioned Carterv. STAAR Surgical Company et al., 8:25-cv-01993 (filed September 5, 2025) (the “Complaint”). The Complaint generally alleges that the Preliminary Proxy misrepresents and/or omits certain purportedly material information. The Complaint asserts violations of Sections 14(a) and 20(a) of the Exchange Act and Rule 14a-9 promulgated thereunder against STAAR and the members of the STAAR Board. The Complaint seeks, among other things: an injunction enjoining the consummation of the Merger; rescission or rescissory damages in the event the Merger is consummated; direction that defendants cause a revised proxy statement to be disseminated; costs of the action, including plaintiffs’ attorneys’ fees and experts’ fees; and other relief the court may deem just and proper. In addition to the Complaint, several purported stockholders of STAAR sent demand letters (the “Demands,” and together with the Complaint, the “Matters”) alleging similar deficiencies regarding the disclosures made in the Preliminary Proxy. STAAR cannot predict the outcome of the Matters, but believes that the Matters are